The Lymphoma Drugs Market is witnessing robust growth as the prevalence of Hodgkin’s and non-Hodgkin’s lymphoma continues to rise globally. Advancements in targeted therapies, immunotherapies, and personalized medicine are transforming treatment approaches, enhancing efficacy while min